Related Experiment Video
Updated: May 31, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Update on the optimal use of voriconazole for invasive fungal infections
1Department of Pharmacy, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA;
Abstract:
Voriconazole is an extended-spectrum triazole with excellent bioavailability that has now become the treatment of choice for aspergillosis. It has a unique side effect profile compared with other azoles, as well as a number of clinically important drug-drug interactions. These factors, along with a correlation between increased serum levels and improved outcomes, have prompted an interest in therapeutic drug monitoring of this agent. The pharmacology and clinical outcomes data of voriconazole are presented in this review.
Related Concept Videos
Antifungal Agents
Candidiasis
Cryptococcal Meningitis
Endocarditis III: Medical Management
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
